BE840253A - Compose utilisables dans le traitement des infections bacteriennes - Google Patents

Compose utilisables dans le traitement des infections bacteriennes

Info

Publication number
BE840253A
BE840253A BE165741A BE165741A BE840253A BE 840253 A BE840253 A BE 840253A BE 165741 A BE165741 A BE 165741A BE 165741 A BE165741 A BE 165741A BE 840253 A BE840253 A BE 840253A
Authority
BE
Belgium
Prior art keywords
compounds
treatment
bacterial infections
infections
bacterial
Prior art date
Application number
BE165741A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE840253A publication Critical patent/BE840253A/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/429Thiazoles condensed with heterocyclic ring systems
    • A61K31/43Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D503/00Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
BE165741A 1975-04-14 1976-03-31 Compose utilisables dans le traitement des infections bacteriennes BE840253A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB15209/75A GB1545467A (en) 1975-04-14 1975-04-14 Deoxyclavulanic acid and deoxyisoclavulanic acid and derivatives thereof

Publications (1)

Publication Number Publication Date
BE840253A true BE840253A (fr) 1976-09-30

Family

ID=10054957

Family Applications (1)

Application Number Title Priority Date Filing Date
BE165741A BE840253A (fr) 1975-04-14 1976-03-31 Compose utilisables dans le traitement des infections bacteriennes

Country Status (5)

Country Link
BE (1) BE840253A (fr)
GB (1) GB1545467A (fr)
IN (1) IN142091B (fr)
ZA (1) ZA761953B (fr)
ZM (1) ZM4076A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4123540A (en) 1974-12-18 1978-10-31 Beecham Group Limited Isoclavulanic acid as an antibacterial and a β-lactamase inhibitor
US4166904A (en) * 1977-02-26 1979-09-04 Beecham Group Limited ⊕-lactam containing compounds

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4123540A (en) 1974-12-18 1978-10-31 Beecham Group Limited Isoclavulanic acid as an antibacterial and a β-lactamase inhibitor
US4166904A (en) * 1977-02-26 1979-09-04 Beecham Group Limited ⊕-lactam containing compounds

Also Published As

Publication number Publication date
IN142091B (fr) 1977-05-28
ZA761953B (en) 1977-04-27
GB1545467A (en) 1979-05-10
ZM4076A1 (en) 1977-09-21

Similar Documents

Publication Publication Date Title
FR2273509A1 (fr) Article pour le traitement des menstrues
BE875945A (fr) Derives anthraquinoniques pour le traitement des arthrites
FR2338687A1 (fr) Endoscope pour le traitement de strictions uretrales
IT1036563B (it) Composizione per il trattamento ritaroato delle ferite apeerte contaminate
IT1062533B (it) Composizione per il trattamento di tessuti
BE843359A (fr) Preparation pour le traitement de parodontose
BE807080A (fr) Compositions pour le traitement de surfaces
FR2299379A1 (fr) Compositions de traitement de surface
BE828555A (fr) Composition pour le traitement d'infections virales
BE840614A (fr) Compositions pour le traitement des etoffes
BE859851A (fr) Traitement d'infections bacteriennes
BE793792A (fr) Compositions pour le traitement de la peau
NL7607203A (nl) Behandeling van mineralen.
BE811068A (fr) Composition pour le traitement des cheveux
FR2306710A1 (fr) Composition pour le traitement du colon
SE7609100L (sv) Hudbehandlingskomposition
BE841018A (fr) Conteneur de traitement
FR2342058A1 (fr) Composition pour le traitement des cheveux
FR2300547A1 (fr) Agents pour le traitement des cheveux
IT1069108B (it) Composizione per il trattamento di infezioni da funghi nel bestiame
BE840253A (fr) Compose utilisables dans le traitement des infections bacteriennes
BE841614A (fr) Traitement des animaux
FR2311553A1 (fr) Medicament pour le traitement de la schizophrenie
IT1057861B (it) Composizione per la diagnosi ed il trattamento di infezioni microbiche
SE389018B (sv) Forfarande for framstellning av en komposition till anvendning vid behandling av urinvegsinfektioner orsakade av karbamidspjelkande bakterier